JPS6431766A - Thrombocyte promoter antagonistic compound - Google Patents

Thrombocyte promoter antagonistic compound

Info

Publication number
JPS6431766A
JPS6431766A JP63171720A JP17172088A JPS6431766A JP S6431766 A JPS6431766 A JP S6431766A JP 63171720 A JP63171720 A JP 63171720A JP 17172088 A JP17172088 A JP 17172088A JP S6431766 A JPS6431766 A JP S6431766A
Authority
JP
Japan
Prior art keywords
lower alkyl
aryl
hydrogen
independently
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63171720A
Other languages
Japanese (ja)
Inventor
Uiriamu Gasurii Robaato
Waitoman Kiaasutets Richiyaado
Raito Teirei Jiefuaason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS6431766A publication Critical patent/JPS6431766A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compounds of the formula <IMAGE> I Y is O ir S, *A is paraphenylene or *--(CH2)n--(X)m-(CH2)r--, X is O, S or -CH=CH-, n or r, independently, are integers from 0 to 3, s is an integer from 0 to 1, m is an integer from 0 to 1, provided that when m is 1, n+s must be at least 2, R1 and R2, independently, are hydrogen, lower alkyl, cycloalkyl, lower alkenyl, Het, aryl, R3, R4 and R8, independently, are hydrogen, lower alkyl, aryl, R5 and R6, independently, are hydrogen or lower alkyl, R7 is hydrogen, lower alkyl, cycloalkyl, Het-lower alkyl or aryl, Het is a monocyclic 5- or 6-membered hetero aromatic or a bicyclic heteroaromatic radical containing one or two hetero atoms selected from nitrogen, oxygen and sulfur, which radical may be substituted by lower alkyl, halogen or aryl, and the asterisk denotes the point of attachment, and when R6 and R7 are different, their enantiomers and racemic mixtures thereof, when R1 and R2 are different, their geometric isomers, and pharmaceutically acceptable acid addition salts thereof, are described. The compounds of formula I exhibit activity as platelet activating factor (PAF) antagonists and are, therefore, useful in disease states characerized by excess platelet activating factor or for the prevention and treatment of cardiovascular disease, pulmonary diseases, immunological disorders, inflammatory diseases, dermatological disorders, shock or transplant rejection.
JP63171720A 1987-07-10 1988-07-10 Thrombocyte promoter antagonistic compound Pending JPS6431766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/072,389 US4788206A (en) 1987-07-10 1987-07-10 Pentadieneamides

Publications (1)

Publication Number Publication Date
JPS6431766A true JPS6431766A (en) 1989-02-02

Family

ID=22107243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63171720A Pending JPS6431766A (en) 1987-07-10 1988-07-10 Thrombocyte promoter antagonistic compound

Country Status (21)

Country Link
US (1) US4788206A (en)
EP (1) EP0299379B1 (en)
JP (1) JPS6431766A (en)
KR (1) KR890001989A (en)
AT (1) ATE88466T1 (en)
AU (1) AU626526B2 (en)
CZ (1) CZ394991A3 (en)
DE (1) DE3880387D1 (en)
DK (1) DK378188A (en)
ES (1) ES2054740T3 (en)
FI (1) FI883290A (en)
HU (1) HU205902B (en)
IL (1) IL87017A0 (en)
MC (1) MC1954A1 (en)
MX (1) MX9203599A (en)
NO (1) NO883084L (en)
NZ (1) NZ225327A (en)
PH (1) PH24605A (en)
PT (1) PT87953B (en)
YU (1) YU46716B (en)
ZA (1) ZA884857B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043241A1 (en) * 1996-05-13 1997-11-20 Nippon Shinyaku Co., Ltd. Substituted ethylene compounds and drugs
JP2006505494A (en) * 2002-02-20 2006-02-16 アボット・ラボラトリーズ Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptors
JP2006519874A (en) * 2003-03-05 2006-08-31 セルジーン・コーポレーション Diphenylethylene compounds and uses thereof
WO2008007780A1 (en) * 2006-07-13 2008-01-17 Kyowa Hakko Kirin Co., Ltd. Pentadienamide derivative
JP2008247903A (en) * 1996-04-23 2008-10-16 Targacept Inc Pharmaceutical formulation for preventing and treating central nervous system disorder
US7767705B2 (en) 2006-08-25 2010-08-03 Abbott Laboratories Compounds that inhibit TRPV1 and uses thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225307A (en) * 1987-07-10 1991-06-25 Hoffmann La Roche Heterocyclic containing alkene derivatives and pharmaceutical compositions
US5192766A (en) * 1989-04-28 1993-03-09 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists
US5369106A (en) * 1989-04-28 1994-11-29 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists
KR100568997B1 (en) * 1996-04-23 2006-12-15 타가셉트 인코포레이티드 Pharmaceutical Compositions for the Prevention and Treatment of CNS Diseases
JP2001525400A (en) * 1997-12-11 2001-12-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Retinoic acid pseudoanilide
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
DE19828463A1 (en) * 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadienes as water-soluble, photostable UV filters for cosmetic and pharmaceutical preparations
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
WO2000075110A1 (en) * 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
BRPI0511834A (en) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc methods for treating hepatitis c
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007000762A (en) * 2004-07-22 2007-04-02 Ptc Therapeutics Inc Thienopyridines for treating hepatitis c.
BRPI0917819B8 (en) * 2008-08-22 2021-05-25 Baxalta GmbH polymeric benzyl carbonate derivative compounds, drug conjugate, pharmaceutical formulation, and use of a conjugate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072649A (en) * 1963-01-08 S-tmalkoxycinnamamide derivatives
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
US4568685A (en) * 1984-02-29 1986-02-04 American Cyanamid Company N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides
US4542145A (en) * 1984-02-29 1985-09-17 American Cyanamid Company Substituted N-[(1H-1,2,4-triazol-1-yl)-alkyl]heteroarylcarboxamides
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
JPS6144869A (en) * 1984-08-10 1986-03-04 Terumo Corp Imidazole derivative and inhibitor of blood platelet aggregation containing same
JPS6144870A (en) * 1984-08-10 1986-03-04 Terumo Corp Unsaturated fatty acid amide derivative and inhibitor of blood platelet aggregation containing same
JPS6212757A (en) * 1985-07-10 1987-01-21 Yoshitomi Pharmaceut Ind Ltd Cinnamic acid amide derivative
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
JPH06144869A (en) * 1992-11-10 1994-05-24 Matsunami Glass Kogyo Kk Porous glass for biological carrier

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008247903A (en) * 1996-04-23 2008-10-16 Targacept Inc Pharmaceutical formulation for preventing and treating central nervous system disorder
WO1997043241A1 (en) * 1996-05-13 1997-11-20 Nippon Shinyaku Co., Ltd. Substituted ethylene compounds and drugs
JP2006505494A (en) * 2002-02-20 2006-02-16 アボット・ラボラトリーズ Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptors
JP2011026326A (en) * 2002-02-20 2011-02-10 Abbott Lab Fused azabicyclic compounds which inhibit vanilloid receptor subtype 1 (vr1) receptor
JP2006519874A (en) * 2003-03-05 2006-08-31 セルジーン・コーポレーション Diphenylethylene compounds and uses thereof
WO2008007780A1 (en) * 2006-07-13 2008-01-17 Kyowa Hakko Kirin Co., Ltd. Pentadienamide derivative
US7767705B2 (en) 2006-08-25 2010-08-03 Abbott Laboratories Compounds that inhibit TRPV1 and uses thereof
US8815930B2 (en) 2006-08-25 2014-08-26 Abbvie Inc. Compounds that inhibit TRPV1 and uses thereof

Also Published As

Publication number Publication date
US4788206A (en) 1988-11-29
MC1954A1 (en) 1989-06-30
KR890001989A (en) 1989-04-07
YU132488A (en) 1991-02-28
AU1885188A (en) 1989-01-12
ATE88466T1 (en) 1993-05-15
EP0299379A1 (en) 1989-01-18
PT87953B (en) 1995-03-01
YU46716B (en) 1994-04-05
HU205902B (en) 1992-07-28
AU626526B2 (en) 1992-08-06
ES2054740T3 (en) 1994-08-16
PH24605A (en) 1990-08-17
DK378188A (en) 1989-01-11
EP0299379B1 (en) 1993-04-21
NZ225327A (en) 1991-08-27
PT87953A (en) 1989-06-30
DE3880387D1 (en) 1993-05-27
FI883290A0 (en) 1988-07-08
HUT48594A (en) 1989-06-28
MX9203599A (en) 1992-07-01
NO883084D0 (en) 1988-07-08
NO883084L (en) 1989-01-11
DK378188D0 (en) 1988-07-07
CZ394991A3 (en) 1993-01-13
ZA884857B (en) 1989-04-26
IL87017A0 (en) 1988-12-30
FI883290A (en) 1989-01-11

Similar Documents

Publication Publication Date Title
JPS6431766A (en) Thrombocyte promoter antagonistic compound
HUT56082A (en) Process for producing 4-benzoyl-isoxazol derivatives and fungicide compositions containing them as active components
BG60030B2 (en) Method for the preparation of /d/-ethyl-2-oxo-1-pirrolidineacetamide
ES2058257T5 (en) HERBICIDE COMPOUNDS.
DZ863A1 (en) Benzoxazol and benzothiazolamine derivatives.
IL70528A (en) Pharmaceutical compositions comprising derivatives of naphthalene-or azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation
ES2056889T3 (en) DERIVATIVES OF TRIAZOLDIACEPINE.
EP0298466A3 (en) Substituted alkene carboxylic acid amides and derivatives
DE3561513D1 (en) 3n-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions
IL96762A0 (en) Pyridyl cyclopropane derivatives,process for their preparation and fungicidal compositions containing them
DE69012653D1 (en) Heterocyclic triazine or triazolo compounds with serotonin 2 receptor antagonist activity.
MX15697A (en) HETEROTETRACICLIC DERIVATIVES OF LACTAMA AND PROCESS FOR ITS PREPARATION
EP0089730A3 (en) Guanidino heterocyclicphenylamidines, processes for their preparation and their pharmaceutical use
HUT38625A (en) Process for preparing 1,5-benzoxathiepine derivatives and pharmaceutical compositions containing such compounds
GB8907306D0 (en) New compositions of matter
TH14924EX (en) Fungicide derivatives, various preparations and uses of them.